Koike et al. reviewed 894 patients with peripheral clinical stage IA non-small cell lung cancer and reported that the preoperative serum CEA level, tumor size and consolidation/tumor ratio were risk factors. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.